Developer of novel drug therapies intended to restore voluntary control of excretory function to neurologically impaired people. The company provides effective and convenient pharmaceutical agents that trigger the voiding of bladder and bowel contents when the person wishes, enabling patients with spinal cord injury, spina bifida, and other neurological conditions to have an enhanced way of life.